DUAL CHECKPOINT ABROGATION IS SYNERGISTIC IN KRAS-MUTANT CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 09期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：903 / 903
页数：1
相关论文
共 50 条
  • [1] Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer
    Zhong, Longhui
    Wang, Rong
    Wang, Yanxia
    Peng, Shunli
    Ma, Yueyun
    Ding, Sijie
    Yang, Hong
    Chen, Shiyu
    Luo, Xiaoqing
    Wang, Wei
    NEOPLASIA, 2020, 22 (09): : 365 - 375
  • [2] Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer
    Hanada, Keita
    Kawada, Kenji
    Nishikawa, Gen
    Toda, Kosuke
    Maekawa, Hisatsugu
    Nishikawa, Yasuyo
    Masui, Hideyuki
    Hirata, Wataru
    Okamoto, Michio
    Kiyasu, Yoshiyuki
    Honma, Shusaku
    Ogawa, Ryotaro
    Mizuno, Rei
    Itatani, Yoshiro
    Miyoshi, Hiroyuki
    Sasazuki, Takehiko
    Shirasawa, Senji
    Taketo, M. Mark
    Obama, Kazutaka
    Sakai, Yoshiharu
    CANCER LETTERS, 2021, 522 : 129 - 141
  • [3] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [4] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
  • [5] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [6] Genetic modifiers of KRAS-mutant colorectal cancer
    Tjader, Nijole P.
    Ramroop, Johnny
    Gandhi, Tanish
    Campbell, Peter T.
    Chan, Andrew T.
    Gallinger, Steven
    Giles, Graham G.
    Gunter, Marc J.
    Harrison, Tabitha A.
    Hoffmeister, Michael
    Newcomb, Polly A.
    Ogino, Shuji
    Phipps, Amanda I.
    Qu, Conghui
    Schoen, Robert E.
    Pellatt, Andrew
    Woods, Michael O.
    Van Guelpen, Bethany
    Stevens, Patrick
    Hampel, Heather
    Peters, Ulrike
    McElroy, Joseph P.
    Toland, Amanda E.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [8] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
    Li, Yunchang
    Hu, Lanlin
    Peng, Xinhao
    Xu, Huasheng
    Tang, Bo
    Xu, Chuan
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 129 - 146
  • [9] A combinatorial strategy for treating KRAS-mutant lung cancer
    Eusebio Manchado
    Susann Weissmueller
    John P. Morris
    Chi-Chao Chen
    Ramona Wullenkord
    Amaia Lujambio
    Elisa de Stanchina
    John T. Poirier
    Justin F. Gainor
    Ryan B. Corcoran
    Jeffrey A. Engelman
    Charles M. Rudin
    Neal Rosen
    Scott W. Lowe
    Nature, 2016, 534 : 647 - 651
  • [10] A combinatorial strategy for treating KRAS-mutant lung cancer
    Manchado, Eusebio
    Weissmueller, Susann
    Morris, John P.
    Chen, Chi-Chao
    Wullenkord, Ramona
    Lujambio, Amaia
    de Stanchina, Elisa
    Poirier, John T.
    Gainor, Justin F.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    Rudin, Charles M.
    Rosen, Neal
    Lowe, Scott W.
    NATURE, 2016, 534 (7609) : 647 - +
12345